Global Exosome Platform Supply, Demand and Key Producers, 2023-2029

Description

The global Exosome Platform market size is expected to reach $ 2799.6 million by 2029, rising at a market growth of 10.8% CAGR during the forecast period (2023-2029).

Exosomes are present in all body fluids under both normal and pathophysiological conditions. Exosomes are extracellular vesicles (EVs) with a size range of ~40 to 160 nm (average ~100 nm) in diameter with an endosomal origin. Depending on the cell of origin, exosomes can contain many constituents of a cell, including DNA, RNA, lipids, metabolites, and cytosolic and cell-surface proteins. The physiological purpose of generating exosomes remains largely unknown and needs investigation. Intercellular communication through exosomes seems to be involved in the pathogenesis of various disorders, including cancer, neurodegeneration, and inflammatory diseases.

This report studies the global Exosome Platform demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Exosome Platform, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Exosome Platform that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Exosome Platform total market, 2018-2029, (USD Million)
Global Exosome Platform total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Exosome Platform total market, key domestic companies and share, (USD Million)
Global Exosome Platform revenue by player and market share 2018-2023, (USD Million)
Global Exosome Platform total market by Type, CAGR, 2018-2029, (USD Million)
Global Exosome Platform total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Exosome Platform market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Exosome Diagnostics, Lifeasible, Creative Bioarray, ReNeuron, Evox Therapeutics, Everzom, LipExoGen Biotech, Immunostep Biotech and AMSBIO, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Exosome Platform market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Exosome Platform Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Exosome Platform Market, Segmentation by Type
    Exosome Isolation
    Exosome Identification
    Exosome Analysis
    Other

Global Exosome Platform Market, Segmentation by Application
    Academic and Research Institutes
    Pharmaceutical and Biotechnology Company
    Hospitals and Clinical
    Testing Laboratories
    Others

Companies Profiled:
    Exosome Diagnostics
    Lifeasible
    Creative Bioarray
    ReNeuron
    Evox Therapeutics
    Everzom
    LipExoGen Biotech
    Immunostep Biotech
    AMSBIO
    Frontage Labs
    System Biosicences (SBI)
    RoosterBio
    Clara Biotech
    Luminous BioSciences
    Wayen Biotechnologies (Shanghai)
    Shanghai Yanjiang Biotechnology

Key Questions Answered
1. How big is the global Exosome Platform market?
2. What is the demand of the global Exosome Platform market?
3. What is the year over year growth of the global Exosome Platform market?
4. What is the total value of the global Exosome Platform market?
5. Who are the major players in the global Exosome Platform market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Exosome Platform Introduction
    1.2 World Exosome Platform Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Exosome Platform Total Market by Region (by Headquarter Location)
        1.3.1 World Exosome Platform Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Exosome Platform Market Size (2018-2029)
        1.3.3 China Exosome Platform Market Size (2018-2029)
        1.3.4 Europe Exosome Platform Market Size (2018-2029)
        1.3.5 Japan Exosome Platform Market Size (2018-2029)
        1.3.6 South Korea Exosome Platform Market Size (2018-2029)
        1.3.7 ASEAN Exosome Platform Market Size (2018-2029)
        1.3.8 India Exosome Platform Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Exosome Platform Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Exosome Platform Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Exosome Platform Consumption Value (2018-2029)
    2.2 World Exosome Platform Consumption Value by Region
        2.2.1 World Exosome Platform Consumption Value by Region (2018-2023)
        2.2.2 World Exosome Platform Consumption Value Forecast by Region (2024-2029)
    2.3 United States Exosome Platform Consumption Value (2018-2029)
    2.4 China Exosome Platform Consumption Value (2018-2029)
    2.5 Europe Exosome Platform Consumption Value (2018-2029)
    2.6 Japan Exosome Platform Consumption Value (2018-2029)
    2.7 South Korea Exosome Platform Consumption Value (2018-2029)
    2.8 ASEAN Exosome Platform Consumption Value (2018-2029)
    2.9 India Exosome Platform Consumption Value (2018-2029)

3 World Exosome Platform Companies Competitive Analysis
    3.1 World Exosome Platform Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Exosome Platform Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Exosome Platform in 2022
        3.2.3 Global Concentration Ratios (CR8) for Exosome Platform in 2022
    3.3 Exosome Platform Company Evaluation Quadrant
    3.4 Exosome Platform Market: Overall Company Footprint Analysis
        3.4.1 Exosome Platform Market: Region Footprint
        3.4.2 Exosome Platform Market: Company Product Type Footprint
        3.4.3 Exosome Platform Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Exosome Platform Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Exosome Platform Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Exosome Platform Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Exosome Platform Consumption Value Comparison
        4.2.1 United States VS China: Exosome Platform Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Exosome Platform Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Exosome Platform Companies and Market Share, 2018-2023
        4.3.1 United States Based Exosome Platform Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Exosome Platform Revenue, (2018-2023)
    4.4 China Based Companies Exosome Platform Revenue and Market Share, 2018-2023
        4.4.1 China Based Exosome Platform Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Exosome Platform Revenue, (2018-2023)
    4.5 Rest of World Based Exosome Platform Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Exosome Platform Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Exosome Platform Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Exosome Platform Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Exosome Isolation
        5.2.2 Exosome Identification
        5.2.3 Exosome Analysis
        5.2.4 Other
    5.3 Market Segment by Type
        5.3.1 World Exosome Platform Market Size by Type (2018-2023)
        5.3.2 World Exosome Platform Market Size by Type (2024-2029)
        5.3.3 World Exosome Platform Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Exosome Platform Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Academic and Research Institutes
        6.2.2 Pharmaceutical and Biotechnology Company
        6.2.3 Hospitals and Clinical
        6.2.4 Testing Laboratories
        6.2.5 Testing Laboratories
    6.3 Market Segment by Application
        6.3.1 World Exosome Platform Market Size by Application (2018-2023)
        6.3.2 World Exosome Platform Market Size by Application (2024-2029)
        6.3.3 World Exosome Platform Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Exosome Diagnostics
        7.1.1 Exosome Diagnostics Details
        7.1.2 Exosome Diagnostics Major Business
        7.1.3 Exosome Diagnostics Exosome Platform Product and Services
        7.1.4 Exosome Diagnostics Exosome Platform Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Exosome Diagnostics Recent Developments/Updates
        7.1.6 Exosome Diagnostics Competitive Strengths & Weaknesses
    7.2 Lifeasible
        7.2.1 Lifeasible Details
        7.2.2 Lifeasible Major Business
        7.2.3 Lifeasible Exosome Platform Product and Services
        7.2.4 Lifeasible Exosome Platform Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Lifeasible Recent Developments/Updates
        7.2.6 Lifeasible Competitive Strengths & Weaknesses
    7.3 Creative Bioarray
        7.3.1 Creative Bioarray Details
        7.3.2 Creative Bioarray Major Business
        7.3.3 Creative Bioarray Exosome Platform Product and Services
        7.3.4 Creative Bioarray Exosome Platform Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Creative Bioarray Recent Developments/Updates
        7.3.6 Creative Bioarray Competitive Strengths & Weaknesses
    7.4 ReNeuron
        7.4.1 ReNeuron Details
        7.4.2 ReNeuron Major Business
        7.4.3 ReNeuron Exosome Platform Product and Services
        7.4.4 ReNeuron Exosome Platform Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 ReNeuron Recent Developments/Updates
        7.4.6 ReNeuron Competitive Strengths & Weaknesses
    7.5 Evox Therapeutics
        7.5.1 Evox Therapeutics Details
        7.5.2 Evox Therapeutics Major Business
        7.5.3 Evox Therapeutics Exosome Platform Product and Services
        7.5.4 Evox Therapeutics Exosome Platform Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Evox Therapeutics Recent Developments/Updates
        7.5.6 Evox Therapeutics Competitive Strengths & Weaknesses
    7.6 Everzom
        7.6.1 Everzom Details
        7.6.2 Everzom Major Business
        7.6.3 Everzom Exosome Platform Product and Services
        7.6.4 Everzom Exosome Platform Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Everzom Recent Developments/Updates
        7.6.6 Everzom Competitive Strengths & Weaknesses
    7.7 LipExoGen Biotech
        7.7.1 LipExoGen Biotech Details
        7.7.2 LipExoGen Biotech Major Business
        7.7.3 LipExoGen Biotech Exosome Platform Product and Services
        7.7.4 LipExoGen Biotech Exosome Platform Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 LipExoGen Biotech Recent Developments/Updates
        7.7.6 LipExoGen Biotech Competitive Strengths & Weaknesses
    7.8 Immunostep Biotech
        7.8.1 Immunostep Biotech Details
        7.8.2 Immunostep Biotech Major Business
        7.8.3 Immunostep Biotech Exosome Platform Product and Services
        7.8.4 Immunostep Biotech Exosome Platform Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Immunostep Biotech Recent Developments/Updates
        7.8.6 Immunostep Biotech Competitive Strengths & Weaknesses
    7.9 AMSBIO
        7.9.1 AMSBIO Details
        7.9.2 AMSBIO Major Business
        7.9.3 AMSBIO Exosome Platform Product and Services
        7.9.4 AMSBIO Exosome Platform Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 AMSBIO Recent Developments/Updates
        7.9.6 AMSBIO Competitive Strengths & Weaknesses
    7.10 Frontage Labs
        7.10.1 Frontage Labs Details
        7.10.2 Frontage Labs Major Business
        7.10.3 Frontage Labs Exosome Platform Product and Services
        7.10.4 Frontage Labs Exosome Platform Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Frontage Labs Recent Developments/Updates
        7.10.6 Frontage Labs Competitive Strengths & Weaknesses
    7.11 System Biosicences (SBI)
        7.11.1 System Biosicences (SBI) Details
        7.11.2 System Biosicences (SBI) Major Business
        7.11.3 System Biosicences (SBI) Exosome Platform Product and Services
        7.11.4 System Biosicences (SBI) Exosome Platform Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 System Biosicences (SBI) Recent Developments/Updates
        7.11.6 System Biosicences (SBI) Competitive Strengths & Weaknesses
    7.12 RoosterBio
        7.12.1 RoosterBio Details
        7.12.2 RoosterBio Major Business
        7.12.3 RoosterBio Exosome Platform Product and Services
        7.12.4 RoosterBio Exosome Platform Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 RoosterBio Recent Developments/Updates
        7.12.6 RoosterBio Competitive Strengths & Weaknesses
    7.13 Clara Biotech
        7.13.1 Clara Biotech Details
        7.13.2 Clara Biotech Major Business
        7.13.3 Clara Biotech Exosome Platform Product and Services
        7.13.4 Clara Biotech Exosome Platform Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Clara Biotech Recent Developments/Updates
        7.13.6 Clara Biotech Competitive Strengths & Weaknesses
    7.14 Luminous BioSciences
        7.14.1 Luminous BioSciences Details
        7.14.2 Luminous BioSciences Major Business
        7.14.3 Luminous BioSciences Exosome Platform Product and Services
        7.14.4 Luminous BioSciences Exosome Platform Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Luminous BioSciences Recent Developments/Updates
        7.14.6 Luminous BioSciences Competitive Strengths & Weaknesses
    7.15 Wayen Biotechnologies (Shanghai)
        7.15.1 Wayen Biotechnologies (Shanghai) Details
        7.15.2 Wayen Biotechnologies (Shanghai) Major Business
        7.15.3 Wayen Biotechnologies (Shanghai) Exosome Platform Product and Services
        7.15.4 Wayen Biotechnologies (Shanghai) Exosome Platform Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Wayen Biotechnologies (Shanghai) Recent Developments/Updates
        7.15.6 Wayen Biotechnologies (Shanghai) Competitive Strengths & Weaknesses
    7.16 Shanghai Yanjiang Biotechnology
        7.16.1 Shanghai Yanjiang Biotechnology Details
        7.16.2 Shanghai Yanjiang Biotechnology Major Business
        7.16.3 Shanghai Yanjiang Biotechnology Exosome Platform Product and Services
        7.16.4 Shanghai Yanjiang Biotechnology Exosome Platform Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 Shanghai Yanjiang Biotechnology Recent Developments/Updates
        7.16.6 Shanghai Yanjiang Biotechnology Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Exosome Platform Industry Chain
    8.2 Exosome Platform Upstream Analysis
    8.3 Exosome Platform Midstream Analysis
    8.4 Exosome Platform Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Exosome Platform Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Exosome Platform Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Exosome Platform Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Exosome Platform Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Exosome Platform Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Exosome Platform Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Exosome Platform Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Exosome Platform Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Exosome Platform Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Exosome Platform Players in 2022
    Table 12. World Exosome Platform Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Exosome Platform Company Evaluation Quadrant
    Table 14. Head Office of Key Exosome Platform Player
    Table 15. Exosome Platform Market: Company Product Type Footprint
    Table 16. Exosome Platform Market: Company Product Application Footprint
    Table 17. Exosome Platform Mergers & Acquisitions Activity
    Table 18. United States VS China Exosome Platform Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Exosome Platform Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Exosome Platform Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Exosome Platform Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Exosome Platform Revenue Market Share (2018-2023)
    Table 23. China Based Exosome Platform Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Exosome Platform Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Exosome Platform Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Exosome Platform Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Exosome Platform Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Exosome Platform Revenue Market Share (2018-2023)
    Table 29. World Exosome Platform Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Exosome Platform Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Exosome Platform Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Exosome Platform Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Exosome Platform Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Exosome Platform Market Size by Application (2024-2029) & (USD Million)
    Table 35. Exosome Diagnostics Basic Information, Area Served and Competitors
    Table 36. Exosome Diagnostics Major Business
    Table 37. Exosome Diagnostics Exosome Platform Product and Services
    Table 38. Exosome Diagnostics Exosome Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Exosome Diagnostics Recent Developments/Updates
    Table 40. Exosome Diagnostics Competitive Strengths & Weaknesses
    Table 41. Lifeasible Basic Information, Area Served and Competitors
    Table 42. Lifeasible Major Business
    Table 43. Lifeasible Exosome Platform Product and Services
    Table 44. Lifeasible Exosome Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Lifeasible Recent Developments/Updates
    Table 46. Lifeasible Competitive Strengths & Weaknesses
    Table 47. Creative Bioarray Basic Information, Area Served and Competitors
    Table 48. Creative Bioarray Major Business
    Table 49. Creative Bioarray Exosome Platform Product and Services
    Table 50. Creative Bioarray Exosome Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Creative Bioarray Recent Developments/Updates
    Table 52. Creative Bioarray Competitive Strengths & Weaknesses
    Table 53. ReNeuron Basic Information, Area Served and Competitors
    Table 54. ReNeuron Major Business
    Table 55. ReNeuron Exosome Platform Product and Services
    Table 56. ReNeuron Exosome Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. ReNeuron Recent Developments/Updates
    Table 58. ReNeuron Competitive Strengths & Weaknesses
    Table 59. Evox Therapeutics Basic Information, Area Served and Competitors
    Table 60. Evox Therapeutics Major Business
    Table 61. Evox Therapeutics Exosome Platform Product and Services
    Table 62. Evox Therapeutics Exosome Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Evox Therapeutics Recent Developments/Updates
    Table 64. Evox Therapeutics Competitive Strengths & Weaknesses
    Table 65. Everzom Basic Information, Area Served and Competitors
    Table 66. Everzom Major Business
    Table 67. Everzom Exosome Platform Product and Services
    Table 68. Everzom Exosome Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Everzom Recent Developments/Updates
    Table 70. Everzom Competitive Strengths & Weaknesses
    Table 71. LipExoGen Biotech Basic Information, Area Served and Competitors
    Table 72. LipExoGen Biotech Major Business
    Table 73. LipExoGen Biotech Exosome Platform Product and Services
    Table 74. LipExoGen Biotech Exosome Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. LipExoGen Biotech Recent Developments/Updates
    Table 76. LipExoGen Biotech Competitive Strengths & Weaknesses
    Table 77. Immunostep Biotech Basic Information, Area Served and Competitors
    Table 78. Immunostep Biotech Major Business
    Table 79. Immunostep Biotech Exosome Platform Product and Services
    Table 80. Immunostep Biotech Exosome Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Immunostep Biotech Recent Developments/Updates
    Table 82. Immunostep Biotech Competitive Strengths & Weaknesses
    Table 83. AMSBIO Basic Information, Area Served and Competitors
    Table 84. AMSBIO Major Business
    Table 85. AMSBIO Exosome Platform Product and Services
    Table 86. AMSBIO Exosome Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. AMSBIO Recent Developments/Updates
    Table 88. AMSBIO Competitive Strengths & Weaknesses
    Table 89. Frontage Labs Basic Information, Area Served and Competitors
    Table 90. Frontage Labs Major Business
    Table 91. Frontage Labs Exosome Platform Product and Services
    Table 92. Frontage Labs Exosome Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Frontage Labs Recent Developments/Updates
    Table 94. Frontage Labs Competitive Strengths & Weaknesses
    Table 95. System Biosicences (SBI) Basic Information, Area Served and Competitors
    Table 96. System Biosicences (SBI) Major Business
    Table 97. System Biosicences (SBI) Exosome Platform Product and Services
    Table 98. System Biosicences (SBI) Exosome Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. System Biosicences (SBI) Recent Developments/Updates
    Table 100. System Biosicences (SBI) Competitive Strengths & Weaknesses
    Table 101. RoosterBio Basic Information, Area Served and Competitors
    Table 102. RoosterBio Major Business
    Table 103. RoosterBio Exosome Platform Product and Services
    Table 104. RoosterBio Exosome Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. RoosterBio Recent Developments/Updates
    Table 106. RoosterBio Competitive Strengths & Weaknesses
    Table 107. Clara Biotech Basic Information, Area Served and Competitors
    Table 108. Clara Biotech Major Business
    Table 109. Clara Biotech Exosome Platform Product and Services
    Table 110. Clara Biotech Exosome Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Clara Biotech Recent Developments/Updates
    Table 112. Clara Biotech Competitive Strengths & Weaknesses
    Table 113. Luminous BioSciences Basic Information, Area Served and Competitors
    Table 114. Luminous BioSciences Major Business
    Table 115. Luminous BioSciences Exosome Platform Product and Services
    Table 116. Luminous BioSciences Exosome Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Luminous BioSciences Recent Developments/Updates
    Table 118. Luminous BioSciences Competitive Strengths & Weaknesses
    Table 119. Wayen Biotechnologies (Shanghai) Basic Information, Area Served and Competitors
    Table 120. Wayen Biotechnologies (Shanghai) Major Business
    Table 121. Wayen Biotechnologies (Shanghai) Exosome Platform Product and Services
    Table 122. Wayen Biotechnologies (Shanghai) Exosome Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Wayen Biotechnologies (Shanghai) Recent Developments/Updates
    Table 124. Shanghai Yanjiang Biotechnology Basic Information, Area Served and Competitors
    Table 125. Shanghai Yanjiang Biotechnology Major Business
    Table 126. Shanghai Yanjiang Biotechnology Exosome Platform Product and Services
    Table 127. Shanghai Yanjiang Biotechnology Exosome Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 128. Global Key Players of Exosome Platform Upstream (Raw Materials)
    Table 129. Exosome Platform Typical Customers
List of Figure
    Figure 1. Exosome Platform Picture
    Figure 2. World Exosome Platform Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Exosome Platform Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Exosome Platform Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Exosome Platform Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Exosome Platform Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Exosome Platform Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Exosome Platform Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Exosome Platform Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Exosome Platform Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Exosome Platform Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Exosome Platform Revenue (2018-2029) & (USD Million)
    Figure 13. Exosome Platform Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Exosome Platform Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Exosome Platform Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Exosome Platform Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Exosome Platform Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Exosome Platform Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Exosome Platform Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Exosome Platform Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Exosome Platform Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Exosome Platform Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Exosome Platform by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Exosome Platform Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Exosome Platform Markets in 2022
    Figure 27. United States VS China: Exosome Platform Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Exosome Platform Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Exosome Platform Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Exosome Platform Market Size Market Share by Type in 2022
    Figure 31. Exosome Isolation
    Figure 32. Exosome Identification
    Figure 33. Exosome Analysis
    Figure 34. Other
    Figure 35. World Exosome Platform Market Size Market Share by Type (2018-2029)
    Figure 36. World Exosome Platform Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 37. World Exosome Platform Market Size Market Share by Application in 2022
    Figure 38. Academic and Research Institutes
    Figure 39. Pharmaceutical and Biotechnology Company
    Figure 40. Hospitals and Clinical
    Figure 41. Testing Laboratories
    Figure 42. Others
    Figure 43. Exosome Platform Industrial Chain
    Figure 44. Methodology
    Figure 45. Research Process and Data Source

Companies Mentioned

Exosome Diagnostics
Lifeasible
Creative Bioarray
ReNeuron
Evox Therapeutics
Everzom
LipExoGen Biotech
Immunostep Biotech
AMSBIO
Frontage Labs
System Biosicences (SBI)
RoosterBio
Clara Biotech
Luminous BioSciences
Wayen Biotechnologies (Shanghai)
Shanghai Yanjiang Biotechnology